COMPLEMENT AND TUMOR-NECROSIS-FACTOR-ALPHA CONTRIBUTE TO MAC-1 (CD11BCD18) UP-REGULATION AND SYSTEMIC NEUTROPHIL ACTIVATION DURING ENDOTOXEMIA IN-VIVO/
R. Witthaut et al., COMPLEMENT AND TUMOR-NECROSIS-FACTOR-ALPHA CONTRIBUTE TO MAC-1 (CD11BCD18) UP-REGULATION AND SYSTEMIC NEUTROPHIL ACTIVATION DURING ENDOTOXEMIA IN-VIVO/, Journal of leukocyte biology, 55(1), 1994, pp. 105-111
The increased expression of Mac-1 (CD11b/CD18) adhesion glycoproteins
on neutrophils was studied using flow cytometry in male Fischer 344 ra
ts treated with 5 mg/kg Salmonella enteritidis endotoxin. A rapid and
sustained threefold increase of Mac-1 expression was observed after en
dotoxin injection. Inhibition of complement activation with the solubl
e complement receptor type 1 (sCR1) completely suppressed the initial
up-regulation of Mac-1 (less than or equal to 15 min) but did not prev
ent the activation during the later phase (30-90 min). During that tim
e period, Mac-1 expression increased in parallel with the concentratio
n of tumor necrosis factor alpha (TNF-alpha) in plasma and could be si
gnificantly attenuated with TNF antiserum. To verify the results, isol
ated human neutrophils were incubated with rat plasma obtained at vari
ous times after endotoxin injection. Using shape change as indicator o
f neutrophil activation, complement and TNF-alpha could be identified
as responsible mediators for neutrophil activation during endotoxemia
in vivo. In contrast, the massive neutrophil accumulation in the liver
after endotoxin was only slightly reduced by sCR1 and unaffected by T
NF antiserum. It is concluded that Mac-1. up-regulation on neutrophils
after endotoxin injection in vivo may have limited relevance for hepa
tic neutrophil infiltration but may be important for the pathogenesis
of endotoxin-induced liver injury by facilitating adherence-dependent
neutrophil cytotoxicity.